Skip to main content
Access Microbiology logoLink to Access Microbiology
. 2024 Aug 5;6(8):000825.v3. doi: 10.1099/acmi.0.000825.v3

Fatal Clostridium septicum gas gangrene complicating ECMO: case report and review of literature

Adrien Turban 1, Vincent Joussellin 2, Caroline Piau 1, Vincent Cattoir 1,3, Yoann Launey 2, Gabriel Eustache 2,*
PMCID: PMC11299951  PMID: 39104453

Abstract

Clostridium septicum gas gangrene is a severe and deadly infection caused by an anaerobic, spore-forming, Gram-positive bacillus. As previously described, two entities are observed: traumatic and spontaneous (or non-traumatic) forms. In this report, we aim to describe the case of a fulminant and ultimately fatal C. septicum myonecrosis occurring in a patient who was first admitted for refractory cardiac arrest and placed on veino-arterial extracorporeal membrane oxygenation (ECMO). Building upon prior studies that have documented cases of spontaneous gas gangrene caused by C. septicum, we provide an updated compilation, focusing on microbiological characteristics of C. septicum, along with the diagnostic and therapeutic challenges associated with spontaneous gas gangrene. Additionally, the specific clinical situation of our case illustrates the seriousness of this infectious complication that combined both spontaneous and traumatic gas gangrene risk factors. We thus, discuss the antibiotic coverage prior to the initiation of ECMO procedure.

Keywords: Clostridium septicum, ECMO complication, gas gangrene

Data Summary

No data were generated during this research or are required for the work to be reproduced.

Introduction

Extracorporeal membrane oxygenation (ECMO) is a final resort method employed in the treatment of patients experiencing severe acute respiratory distress syndrome, cardiogenic shock or refractory cardiac arrest. The substitution system enables blood oxygenation using an external oxygenation membrane. Blood is withdrawn from the human body via a venous catheter and then reintroduced, following oxygenation, through a second venous or arterial catheter, creating a venous-venous or venous-arterial circuit [1,2]. Despite significant progress in care and support of patient undergoing ECMO, mortality in intensive care units (ICUs) remains high: from 43 % in acute respiratory distress syndrome [3] to 61 % in cardiogenic shock [4]. In refractory cardiac arrest cases, the long-term survival and neurological prognosis associated with ECMO effectiveness remains uncertain [5].

Among complications associated with these devices, bleeding and hospital-acquired infections (HAIs) are both frequent and severe, and contribute to the ECMO’s high mortality [6]. HAI prevalence rates range from 10–12 % and are related to an increased risk of mortality, which varies from 38–63 % [1,7]. Among bacterial etiologies, coagulase-negative staphylococci (CoNS) are prevailing, followed by Pseudomonas aeruginosa (10.5 %), Staphylococcus aureus (9.4 %) and Enterococcus spp. (4 %). Notably, recent data suggest a growing significance of Candida spp., of which the implication may potentially surpass that of CoNS [8]. The clinical presentation of HAIs are mostly characterized by pulmonary lesions (56 %) and bacteremia or candidemia (26 %) [8,10]. Skin and soft-tissue infections are also described but remain scarce [8].

Gas gangrene (also called clostridial myonecrosis) is a rare acute infection disease that involved both subcutaneous and muscular tissues. It is mainly caused by Clostridium species such as Clostridium perfringens, Clostridium septicum, Clostridium sordellii, Clostridium histolyticum and Clostridium novyi [11,12]. It is composed of two clinical entities: 1) the traumatic gas gangrene, which represents about 85 % of cases, is caused by accidental (50 %) or surgical (35 %) traumas with the major injury leading to the invasion of soft tissues by clostridial spores through the wound (mostly from an environmental source) [13,14]; 2) the spontaneous (non-traumatic) gas gangrene, that represents about 15 % of cases, which occurs without any external injury and is often associated with gastrointestinal malignancy (61.5 %), other immunosuppression (malignant haematological disorder, chemotherapy or radiotherapy) or diabetes mellitus [12,13, 15,19]. C. perfringens is the major pathogen related to traumatic entities (80 %), while C. septicum is the main species involved in spontaneous cases [12,20,22]. Overall involvement of C. septicum in gas gangrene, whether spontaneous or not, is estimated at 20 % [23] and accounts for 1.3 % of all Clostridium infections [24].

In this case report, we describe the fatal case of a male patient who was first hospitalized for refractory cardiac arrest requiring venous-arterial ECMO, which subsequently led to a C. septicum gas gangrene. To our knowledge, this is the first case in the literature.

Observation

We present the case of a 45-year-old male patient with no prior medical history, except for being overweight (BMI 28.9 kg m−2), who was hospitalized following a refractory cardiac arrest. The symptoms began 48 h before admission with the onset of epigastric pain and bronchial symptoms. He subsequently developed intermittent chest pain, described as burning, without radiation, along with pallor and sweating, prompting the initial call to emergency services. Cardiopulmonary arrest was confirmed by his partner at 04 : 45. Cardiopulmonary resuscitation was initiated immediately (no-flow <1 min). Medical team arrived at 5 : 08 and confirmed cardiopulmonary arrest due to ventricular fibrillation. Three external electrical shocks of 200 joules were delivered with no return to effective circulatory activity before intravenous administration of 300 mg of amiodarone and the first dose of epinephrine (1 mg) at 5 : 14. Orotracheal intubation was performed at 5 : 13, and the EtCO2 was 48 mmHg. The patient was transferred to the University Hospital of Rennes while receiving automated external chest compressions. During the transfer, six additional external electrical shocks of 200 joules were administered, along with a second dose of intravenous amiodarone (150 mg) and intravenous lidocaine (90 mg). Signs of life were observed with limb flexion in response to stimulation and eye opening upon request. Upon arrival at our clinical centre at 6 : 21, there was no spontaneous circulatory activity. Veino-arterial ECMO was initiated at 6 : 38, resulting in a 90 min low-flow period. The femoro-femoral veino-arterial ECMO was established through direct surgical access of the right scarpa. A reperfusion cannula was inserted into the right superficial femoral artery. ECMO flow was set at 5 l min−1 with a r.p.m. of 3900 min−1. The FmO2 was set to obtain a SpO2 ≥92 %. The correct position of cannula was confirmed by echocardiography and chest X-ray. No complications were reported. After haemodynamic stabilization, a coronary angiography revealed acute occlusion of the proximal and mid-right coronary artery. Thromboaspiration was followed by the placement of two active stents. Dual antiplatelet therapy with intravenous lysine acetylsalicylate (250 mg) and oral clopidogrel (600 mg) was initiated along with curative sodium heparin anticoagulation. Echocardiography showed diffuse akinesia, and sub-aortic valve systolic index was measured at 3.5 cm (with ECMO flow set at 5.0 l min−1). The initial evolution was marked by vasoplegia and hypovolemia due to post-resuscitation syndrome. The patient received 10 000 ml of crystalloid solution and norepinephrine up to 0.2 µg/kg min−1 in the first day of intensive care. Sedation and neuromuscular blockade initiated at ECMO implantation were discontinued after 24 h of targeted temperature management (temperature maintained between 35 and 37 °C). Significant signs of awakening were observed with eye opening and limb movements upon request. Thirty-six hours after admission to ICU, the patient presented haemodynamic deterioration. Echocardiographic showed a significant improvement in overall left ventricular systolic function, and the sub-aortic valve systolic index was measured at 9 cm (ECMO flow set at 5.5 l min−1). Norepinephrine was gradually increased up to 1.25 µg/kg min−1. Concurrently, severe hypoxemia (PaO2 67 mmHg despite FiO2 100 % and FmO2 100 %) was observed. Chest X-ray revealed bilateral alveolo-interstitial opacities. Clinically, a unique purplish-violet lesion, 2 cm in size, was noted on the inner surface of the right leg. Empirical antibiotic therapy with a loading dose of 2 g of cefotaxime followed by a 6 g day−1 infusion and a 30 mg kg−1 dose of amikacin was initiated after blood cultures and endotracheal aspiration were performed. At 48 h after admission, epinephrine was added at a dose of 0.5 µg/kg min−1, along with an increase in norepinephrine to 2 µg/kg min−1. Within an hour, a large, extended, and haemorrhagic bullous detachment was observed from the right leg to the right flank and perineum (Fig. 1). Subsequently, subcutaneous crepitus was noted on the right calf.

Fig. 1. Images of the right leg, right flank and perineum.

Fig. 1.

Hematologic tests then revealed anaemia with a haemoglobin level of 5.4 g dl−1 compared to 8.1 g dl−1 2 h earlier. Massive transfusion with seven units of red blood cells, seven units of fresh frozen plasma, and one unit of platelets was initiated in case of haemorrhagic complications. The clinical course deteriorated further with refractory shock, and surgical intervention was deemed futile. A pre-mortem computed tomography (CT) scan revealed emphysematous infiltration of the subcutaneous soft tissues, primarily intramuscular, of the right postero-lateral abdominal wall, extending to the right iliopsoas muscle and the right leg, and the right pectoral muscle. There was extensive emphysematous infiltration of the subcutaneous fatty tissues of the right leg, scrotum, and penis (Fig. 2). Air bubbles were present in the venous network of the right lower limb, extending to the right femoral vein, the inferior vena cava, and the left renal vein. Microbiological culture of endotracheal aspiration revealed a polymorphic flora.

Fig. 2. Pre-mortem CT images.

Fig. 2.

Blood cultures and liquid from haemorrhagic bullae were incubated in both aerobic and anaerobic blood culture bottles. The anaerobic cultures revealed the presence of a Gram-positive, spore-forming bacillus. These anaerobic bottles were then subcultured onto agar plates under anaerobic conditions. Colonies were identified by MALDI-TOF mass spectrometry (Bruker Daltonics, Germany), with both samples yielding positive for C. septicum (Fig. 3). Antibiotic susceptibility was determined using the reference disc-diffusion method, according to 2022 CA-SFM/EUCAST guidelines, with Brucella agar supplemented with 5 % sheep blood, 5 mg l−1 hemin, and 1 mg l−1 vitamin K. C. septicum was susceptible to all tested antibiotics: amoxicillin/clavulanate, piperacillin/tazobactam, imipenem, moxifloxacin, clindamycin, linezolid, vancomycin, and metronidazole (according to 2022 CA-SFM/EUCAST clinical breakpoints). The patient succumbed 58 h after hospital admission.

Fig. 3. Blood culture showing Gram-positive, spore forming bacillus.

Fig. 3.

Clostridium septicum

C. septicum is an opportunistic, anaerobic, spore-forming Gram-positive bacillus. These spores represent the resistance and dissemination form of Clostridium species. It is often found in the soil and in animal digestive tracts [17,23, 25]. Whether C. septicum is a normal commensal bacteria in the human gut remains unclear, however carriage frequency appears to be low [26].

Virulence and toxins

C. septicum exerts several important bacterial factors involved in its virulence. In contrast to other Clostridium species, such as C. perfringens, C. septicum displays an aerotolerant metabolism, thus explaining its ability to proliferate in healthy tissues, even in the absence of a strict anaerobic environment [27]. In a murine model, the bacterial load necessary to cause infection is 300-fold lower than with C. perfringens, and with only a few quantities of spores it can cause fatal disease in immunocompromised patients [27,28]. Like many flagellated bacteria, C. septicum has the ability to develop collective mass swarming behaviour, notably in nutrient-restricted conditions [29], participating to coordinate movements on surfaces, thereby facilitating tissue invasion [29]. Additionally, C. septicum demonstrates the capacity to form biofilms through several features like flagella or biofilm-associated proteins, showing positive correlation with antibiotic resistance and resulting in a worse prognosis [28]. C. septicum virulence relies mostly on the synthesis of a necrotic exotoxin called α-toxin which is coded by the csa gene [30,32]. It belongs to the aerolysin family, like the ε-toxin produced by C. perfringens and a toxin secreted by Aeromonas hydrophila [17,20, 25]. It is initially secreted as an inactive preprotoxin state, subsequently activated by various host proteases, resulting in oligomerization and formation of membrane pores leading to programmed cellular necrosis [17,20, 31, 33]. These membrane pores play a crucial role in tissue necrosis, leading to osmotic cell lysis and an intracellular influx of Ca2+ ions, initiating a signalling cascade resulting in programmed cell necrosis [34]. Additionally, α-toxin leads to decreased tissue perfusion, paving the way for anaerobic conditions to emerge. It also reduces the chemotactic response of neutrophilic polymorphonuclear leukocytes at the site of infection. This toxin induces an increase in capillary permeability, probably explaining frequent metastatic dissemination. Furthermore, α-toxin actively promotes the secretion of HMGB1, a protein that affects neutrophil-dependent antibacterial mechanisms and may participate in the development of a fulminant septic state [16,17, 20, 34,36]. C. septicum also produces other enzymes including β-toxin (DNAse), γ-toxin (hyalurodinase) or δ-toxin (hemolysin), that may contribute to an increased capillary permeability, myonecrosis and toxin dissemination [28]. C. septicum displays many other virulence factors as neuraminidase, protease, sialidase or fibrinolysin which may contribute to systemic dissemination through tissue damages [17,28, 37, 38].

Antibiotics susceptibility

Data on C. septicum remains limited in the literature. It is usually susceptible to penicillin or metronidazole [12,39,41]. In contrast to C. butyricum, C. clostridioforme, C. ramosum or C. innoccum, no β-lactamase has been described in C. septicum. However, resistance to other antibiotics has been described. In a study involving 78 strains, 24.3 % showed resistance to vancomycin [28]. Moreover, resistance to clindamycin appears to be more prevalent, as resistant strains are observed in multiple studies (ranging from 34.6–69 % of tested isolates) [28,41, 42].

C. septicum gas gangrene

Spontaneous gas gangrene

Pathophysiology

Gas gangrene is a deadly disease, showing high mortality (67–100 %), especially in the first hours [12,17]. Spontaneous gas gangrene occurs without any major external trauma. Most of these spontaneous necrotic infections are caused by C. septicum, and several host factors, especially immunosuppression conditions, favour its development [17]. In 2017, Srivastava et al. [17] showed that in patients with spontaneous gas gangrene, 71 % had an underlying malignancy, mostly digestive [17]. The principal hypothesis explaining the high correlation between spontaneous gas gangrene and cancer or immunosuppression lies on the probable association between a transient carriage and host factors. This may result in increased colonization and/or higher susceptibility to infection [17]. Tissue destruction generated by C. septicum virulence factors maintains an anaerobic environment, allowing bacterial multiplication associated with gas production leading to clinical crepitus, characteristic of clostridial gas gangrene [35,43].

Clinical presentation

Clinical features are characterized by progressively increasing muscular pain, often disproportionate regarding clinical impact and mostly affecting the limbs [17,18, 27]. Clinical deterioration appears to be faster than with C. perfringens [27] and rapidly leads to apparition of haemorrhagic bullae, as observed in our case, change in skin coloration and the emergence of tissular necrosis [17]. It is important to note that gas crepitus is not systematically present at diagnosis, and may occur in late stages of the infection [17,44,46]. Timeline between infection and necrosis can be fulminant and can last between 6 to 48 h [18,35, 44, 47]. Progression to septic shock, multi-organ dysfunction and death often occurs rapidly (< 24 h), and mortality rates are higher in myonecrosis secondary to C. septicum (79 %) than in those caused by C. perfringens (32 %) [35].

Diagnosis

Diagnosis of spontaneous gas gangrene can be difficult, mainly due to the lack of a clear entry point, the non-specific initial symptomatology and the rapid evolution toward septic shock. Mean time of incubation is between 12 to 24 h and myonecrosis can extend as fast as 2 cm per hour [17,48]. The diagnosis relies on clinical criteria, as imaging and microbiological samples must not delay medical care [44]. Disparity between severe pain and clinical presentation, rapid haemodynamic deterioration, onset of haemorrhagic bullae or skin necrosis should raise suspicion of necrotic involvement of soft tissues [43,49]. The input of imaging must be restricted to situations where clinical presentation is unclear. However, it should not delay any surgical or medical care [43,47]. X-ray radiography could contribute to faster identification of gas into tissue [35], but this technique shows low sensitivity [44,50], as does ultrasound imaging [43,47]. CT scan has the ability to characterize tissue impairment, reveal gas or evaluate infection evolution. Finally, MRI is an effective method to identify soft tissue necrosis, but access times are often incompatible with emergency situations and CT scan is generally preferred [45,47, 51]. Surgery is also crucial in diagnosis, allowing confirmation of tissular necrosis and microbiological sampling. The identification of spore-forming Gram-positive bacilli should prompt to antibiotics stewardship [17,18, 45].

Therapeutics

The management of these gas gangrenes relies on a medical-surgical approach, where the debridement of necrotic tissues remains the absolute emergency [17,18, 46]. Survival is increased in patients for whom surgery occurs within the first 24 h post-admission, even more within 6 h [46,50]. Medical approach includes probabilistic antibiotic therapy as Infectious Diseases Society of America (IDSA) recommends the use of a large-spectrum association of molecules: vancomycin +piperacillin/tazobactam or a carbapenem. A combination of intravenous penicillin (2–4 million unit/4–6 h) and clindamycin (600–900 mg/8 h), due to its anti-toxin activity, is therefore recommended when Clostridium spp. is identified [18,46, 50, 52, 53]. The place of hyperbaric oxygen in management of gas gangrene remains discussed since the lack of animal and clinical data does not allow for its clear role in those infections. Furthermore, as C. septicum exhibits better aerotolerance, hyperbaric oxygenation is actually not recommended and should not delay surgical intervention [17,18, 43, 46, 50, 52]. Finally, as underlying diseases are often associated with spontaneous gas gangrene, investigation must be done when patient’s condition allows for it.

Review of C. septicum spontaneous gas gangrene literature

In 2017, the review of Srivastava et al. [17] focused on 94 C. septicum spontaneous gas gangrene cases, from 1956 to 2016. To complement the existing data, we carried out an extensive PubMed research for all cases using the terms ‘gas gangrene’, ‘clostridium septicum’ and ‘clostridial myonecrosis’. Through 2017 to 2022, we identified 21 cases in English literature on the basis of title and abstracts [23,54,73] (Table 1). Our review revealed an overall mortality rate of 71 %, and underlying diseases, whether known or not, were present in most cases, with a notable association with digestive malignancies (Table 2). The median age was 64 years, with two cases occurring in paediatric population. In the present review, diabetes mellitus was described in only five cases (24 %) (Table 2), which is less than previous data (41 %) [17]. Implications of diabetes may be related to decreased phagocytosis and chemotactic activity in patients with glycaemic dysregulation diseases [17]. During hospitalization, 71 % of the patients exhibited change in skin coloration (discolouration, erythema, bruising), 43 % had oedema and 43 % had fever. Every single patient experienced important pain and crepitus was found in 66 % (Table 3). Cumulative data of both ours and a previous study [17] shows that a combination of surgical and medical management led to a decreased mortality rate (57 %) compared to cases where only antibiotics or no medical care was considered (86–100 %), emphasizing the importance of multidisciplinary intervention (Table 4). Data available on antibiotics used revealed the frequent association between clindamycin and a β-lactamine (penicillin, piperacillin/tazobactam, cephalosporin or meropenem) (Table 1).

Table 1. Summary of features of C. septicum spontaneous gas gangrene cases between 2017 and 2022.
Years Author Age Sex Treatment Antibiotics Underlying disease Outcomes
2017 Abdulkareem et al. 69 M Surgery+antibiotics Piperacillin/tazobactam+vancomycin Chronic lymphocytic leukaemia Survival
2017 Contou et al. 25 M Surgery+antibiotics Amoxicillin/clavulanic acid+clindamycin+amikacin Leucopenia Death
2017 Cullinane et al. 69 M Surgery+antibiotics Vancomycin+clindamycin+metronidazole Diabetes and cecal tumour Survival
2017 Engen et al. 3 F No treatment No treatment Hemolytic uremic syndrome Death
2017 Mytinger et Kraai 63 M No treatment No treatment Rheumatoid arthritis Death
2018 Thompson et al. 57 M Surgery+antibiotics Not specified Prostate cancer Death
2019 Hussain et al. 23 F Surgery+antibiotics Piperacillin/tazobactam+clindamycin and penicillin Infectious colitis Survival
2019 Saunders et al. 76 F Surgery+antibiotics Not specified Diabetes, intestinal adenocarcinoma Death
2019 Senghaas et al. 72 F Surgery+antibiotics Not specified Breast cancer Survival
2020 Chen et al. 33 M Surgery+antibiotics Not specified Colorectal cancer Death
2020 Grey et al. 56 F Surgery+antibiotics Penicillin+clindamycin+vancomycin Breast cancer Death
2020 Wongboosin et al. 64 M No treatment No treatment Schizophrenia Death
2020 Saiyed et al. 57 F Antibiotics Not specified Mantle cell lymphoma Death
2021 Ben Ismail et al. 58 F Surgery+antibiotics Not specified Diabetes Death
2021 Stoddard et al. 67 M Antibiotics Meropenem Diabetes Death
2021 Parmar et al. 14 F Surgery+antibiotics Ceftazidime+metronidazole and penicillin Burkitt lymphoma Survival
2021 Sivasubramanian et al. 83 M Antibiotics Vancomycin+meropenem+clindamycin Diabetes, colorectal cancer Death
2022 Bickerton et al. 76 F Surgery+antibiotics Piperacillin/tazobactam+clindamycin Colorectal cancer Death
2022 Hechter et al. 77 F Surgery+antibiotics Piperacillin/tazobactam+vancomycin Colorectal cancer Death
2022 Van Asbroeck et al. 84 F Surgery+antibiotics Amoxicillin/clavulanic acid Colorectal cancer Death
2022 Slezak et al. 86 F Surgery+antibiotics Ampicillin/sulbactam+clindamycin+metronidazole Gastrointestinal adenocarcinoma Survival
Table 2. Underlying disease, treatment and blood cultures results of C. septicum spontaneous gas gangrene cases between 2017 and 2022.
N (%) Death (%)
Cases (n) 21 (100) 71
Immunosuppression 15 (71) 66
 Gastrointestinal malignancy 8 (53) 75
 Haematological 4 (26) 50
 Other immunosuppression 3 (20) 66
Diabetes* 5 (24) 80
Treatments
 Surgery+antibiotics 15 (71) 60
 Antibiotics alone 3 (14) 100
 No treatment 3 (14) 100
Blood cultures
 Positive to C. septicum 13 (62) 85
 Negative 1 (5) 0
 Not specified 7 (33) 57

*Diabetes can be associated with immunosuppressive underlying condition.

Table 3. Summary of clinical features during hospitalization.
Symptoms (N=21) N %
Pain 21 100
Fever/chills 9 43
Gastrointestinal disorders 6 28
Hypotension 15 71
Tachycardia 16 76
Septic shock* 11 52
Swelling/oedema 9 43
Skin involvement (discolouration, erythema, bruising) 15 71
Crepitus 14 66

*Patient with septic shock were included in both hypotension and tachycardia criteria.

Table 4. Cumulative data on C. septicum spontaneous gas gangrene following different treatment management.
Srivastava et al. 2017–2022 Cumulative
N (%) Death (%) N (%) Death (%) N (%) Death (%)
Cases 94 67 21 71 115 68
Treatment 74* 21* 95*
 Surgery+antibiotics 54 (73) 56 15 (71) 60 69 (73) 57
 Antibiotics alone 18 (24) 83 3 (14) 100 21 (22) 86
 No treatment 2 (3) 100 3 (14) 100 5 (5) 100

*Only cases where such information was available were included.

Other C. septicum infections

Current literature on C. septicum infections preferentially refers to spontaneous gas gangrene. Few cases describe traumatic presentation, following surgical intervention [49,68, 74,76], after accidental trauma [77,78] or secondary to insulin injection [79], with fatal outcomes in the majority of reported cases. C. septicum is also implicated in other clinical presentations: vascular infections (aortitis [80], aneurysms [24]), endophthalmitis [81], abscesses [82] or even meningitidis [83].

Discussion

To our knowledge, this is the first case of C. septicum gas gangrene following veino-arterial ECMO cannulation. In our report, the source of infection appears to be related to the ECMO implantation site. However, an endogenous origin cannot be ruled out, as low-flow can favour anaerobic conditions, digestive ischemia and bacterial translocation. The rapid and fatal progression of this case raises the question about antibiotic prophylaxis of such life-saving surgical interventions. Indeed, the timing of ECMO implantation is an integral part of low-flow and justifies a need for speed. Despite implantation in a dedicated medical environment, disinfection and demarcation of the operative site with sterile drapes, early infections can still result from inadequate asepsis. Furthermore, the high risk of bacterial infection in the early phase of ECMO implantation, associated with the potential of bacterial translocation due to prolonged no-flow (particularly splanchnic) in the specific case of refractory cardiac arrest could justify antibiotic prophylaxis. Current recommendations (ELSO, Extracorporeal Life Support Organization) do not advocate for antibiotic prophylaxis for these procedures [84]. However, if antibiotic coverage is initiated, it is not recommended to extend it beyond 48 h [84]. Despite the lack of recommendations, 50–68 % of teams still use antibiotic prophylaxis. The most common antibiotics used are cephalosporins, penicillin, vancomycin or aminoglycosides [1]. Notably, there is no clinical data available on the efficacy of these protocols and administration prior to ECMO implantation does not appear to be associated with a decreased infection risk [1].

Conclusion

Gas gangrene due to C. septicum is extremely serious disease, often fatal, and has never been described in the context of extracorporeal circulation. Such an invasive procedure is considered as ‘clean’ procedure (Altemeier class 1) for which no antibiotic is currently recommended. However, in the context of cardiac arrest, as presented in our case, several factors may explain the development of this C. septicum gas gangrene. The fatal outcome of this case could raise the question of using anti-clostridial antibiotics in the coverage of ECMO intervention, but the scarcity of described cases and current data do not allow the drawing of any conclusions and would require further studies.

Abbreviations

BMI

body mass index

CA-SFM/EUCAST

Antibiogram Committee of the French Microbiology Society / European committee on antimicrobial susceptibility testing

CoNS

coagulase-negative staphylococci

CT

computed tomography

DNAse

deoxyribonuclease

ECMO

extracorporeal membrane oxygenation

EtCO2

end-tidal carbon dioxide

FiO2

fraction of inspired oxygen

FmO2

membrane fraction of oxygen

HAI

hospital-acquired infection

MALDI-TOF

matrix assisted laser desorption Ionization - time of flight

PaO2

arterial oxygen tension

r.p.m.

revolution per minute

Footnotes

Funding: The authors received no specific grant from any funding agency.

Ethical statement: Ethics committee opinion not applicable. No opposition from the patient or family to the use of medical data.

Consent to publish: Written informed consent has been received from the patient’s family.

Author contributions: A.T. and G.E. conceived and designed the study. A.T. and G.E. collected data. A.T., V.J. and G.E. analysed and interpreted the data. A.T. and G.E. drafted the report. All authors contributed to the final version. All authors approved the final version.

Contributor Information

Adrien Turban, Email: adrien.turban@chu-rennes.fr.

Vincent Joussellin, Email: vincent.joussellin@chu-rennes.fr.

Caroline Piau, Email: caroline.piau@chu-rennes.fr.

Vincent Cattoir, Email: vincent.cattoir@chu-rennes.fr.

Yoann Launey, Email: yoann.launey@chu-rennes.fr.

Gabriel Eustache, Email: gabriel.eustache@chu-rennes.fr.

References

  • 1.Biffi S, Di Bella S, Scaravilli V, Peri AM, Grasselli G, et al. Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. Int J Antimicrob Agents. 2017;50:9–16. doi: 10.1016/j.ijantimicag.2017.02.025. [DOI] [PubMed] [Google Scholar]
  • 2.Gajkowski EF, Herrera G, Hatton L, Velia Antonini M, Vercaemst L, et al. ELSO guidelines for adult and pediatric extracorporeal membrane oxygenation circuits. ASAIO J. 2022;68:133–152. doi: 10.1097/MAT.0000000000001630. [DOI] [PubMed] [Google Scholar]
  • 3.Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The respiratory extracorporeal membrane oxygenation survival prediction (RESP) score. Am J Respir Crit Care Med. 2014;189:1374–1382. doi: 10.1164/rccm.201311-2023OC. [DOI] [PubMed] [Google Scholar]
  • 4.Paden ML, Conrad SA, Rycus PT, Thiagarajan RR, Registry E. Extracorporeal life support organization registry report 2012. ASAIO J. 2013;59:202–210. doi: 10.1097/MAT.0b013e3182904a52. [DOI] [PubMed] [Google Scholar]
  • 5.Belohlavek J, Smalcova J, Rob D, Franek O, Smid O, et al. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2022;327:737–747. doi: 10.1001/jama.2022.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15:172–178. [PubMed] [Google Scholar]
  • 7.Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P. Extracorporeal life support organization task force on infections, extracorporeal membrane oxygenation. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med Mai. 2011;12:277–281. doi: 10.1097/PCC.0b013e3181e28894. [DOI] [PubMed] [Google Scholar]
  • 8.Gomez F, Veita J, Laudanski K. Antibiotics and ECMO in the adult population-persistent challenges and practical guides. Antibiotics. 2022;11:338. doi: 10.3390/antibiotics11030338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schmidt M, Bréchot N, Hariri S, Guiguet M, Luyt CE, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis. 2012;55:1633–1641. doi: 10.1093/cid/cis783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sun H-Y, Ko W-J, Tsai P-R, Sun C-C, Chang Y-Y, et al. Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg. 2010;140:1125–1132. doi: 10.1016/j.jtcvs.2010.07.017. [DOI] [PubMed] [Google Scholar]
  • 11.Mallozzi M, Viswanathan VK, Vedantam G. Spore-forming Bacilli and Clostridia in human disease. Future Microbiol. 2010;5:1109–1123. doi: 10.2217/fmb.10.60. [DOI] [PubMed] [Google Scholar]
  • 12.Stevens DL, Aldape MJ, Bryant AE. Life-threatening clostridial infections. Anaerobe. 2012;18:254–259. doi: 10.1016/j.anaerobe.2011.11.001. [DOI] [PubMed] [Google Scholar]
  • 13.Gnerlich JL, Ritter JH, Kirby JP, Mazuski JE. Simultaneous necrotizing soft tissue infection and colonic necrosis caused by Clostridium septicum. Surg Infect. 2011;12:501–506. doi: 10.1089/sur.2010.054. [DOI] [PubMed] [Google Scholar]
  • 14.Hamid S, Gadré A, Fornander L, Sjöwall J, Muhrbeck M. Clostridium septicum myonecrosis following gardening: a case report. Int J Surg Case Rep. 2023;105:108000. doi: 10.1016/j.ijscr.2023.108000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Corredoira J, Grau I, Garcia-Rodriguez JF, García-País MJ, Rabuñal R, et al. Colorectal neoplasm in cases of Clostridium septicum and Streptococcus gallolyticus subsp. gallolyticus bacteraemia. Eur J Intern Med. 2017;41:68–73. doi: 10.1016/j.ejim.2017.02.009. [DOI] [PubMed] [Google Scholar]
  • 16.Dahmus JD, Kotler DL, Kastenberg DM, Kistler CA. The gut microbiome and colorectal cancer: a review of bacterial pathogenesis. J Gastrointest Oncol. 2018;9:769–777. doi: 10.21037/jgo.2018.04.07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Srivastava I, Aldape MJ, Bryant AE, Stevens DL. Spontaneous C.septicum gas gangrene: a literature review. Anaerobe. 2017;48:165–171. doi: 10.1016/j.anaerobe.2017.07.008. [DOI] [PubMed] [Google Scholar]
  • 18.Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377:2253–2265. doi: 10.1056/NEJMra1600673. [DOI] [PubMed] [Google Scholar]
  • 19.Yildiz T, Gündeş S, Willke A, Solak M, Toker K. Spontaneous, nontraumatic gas gangrene due to Clostridium perfringens. Int J Infect Dis. 2006;10:83–85. doi: 10.1016/j.ijid.2005.02.005. [DOI] [PubMed] [Google Scholar]
  • 20.Nagahama M, Takehara M, Rood JI. Histotoxic clostridial infections. Microbiol Spectr. 2019;7 doi: 10.1128/microbiolspec.gpp3-0024-2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Laupland KB, Edwards F, Furuya-Kanamori L, Paterson DL, Harris PNA. Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019. Am J Med. 2023;136:896–901. doi: 10.1016/j.amjmed.2023.05.003. [DOI] [PubMed] [Google Scholar]
  • 22.Justesen US, Nielsen SL, Jensen TG, Dessau RB, Møller JK, et al. Bacteremia with anaerobic bacteria and association with colorectal cancer: a population-based cohort study. Clin Infect Dis. 2022;75:1747–1753. doi: 10.1093/cid/ciac259. [DOI] [PubMed] [Google Scholar]
  • 23.Van Asbroeck E, Vasileiadou O, De Laere S, Van Hedent E, Devue K. Clostridium myonecrosis - a rare and underdiagnosed condition in the elderly: a case with severe skipping lesions and an overview of treatment guidelines. Int J Emerg Med. 2022;15:56. doi: 10.1186/s12245-022-00458-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Alimi Y, Sosin M, Borsinger TM, Garrett JR, Salameh JR, et al. Implications of Clostridium septicum in vascular surgery: a case report and outcomes literature review. Ann Vasc Surg. 2017;43:314. doi: 10.1016/j.avsg.2017.03.178. [DOI] [PubMed] [Google Scholar]
  • 25.Alves MLF, Ferreira MRA, Donassolo RA, Rodrigues RR, Conceição FR. Clostridium septicum: a review in the light of alpha-toxin and development of vaccines. Vaccine. 2021;39:4949–4956. doi: 10.1016/j.vaccine.2021.07.019. [DOI] [PubMed] [Google Scholar]
  • 26.Kopliku FA, Schubert AM, Mogle J, Schloss PD, Young VB, et al. Low prevalence of Clostridium septicum fecal carriage in an adult population. Anaerobe. 2015;32:34–36. doi: 10.1016/j.anaerobe.2014.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Stevens DL, Musher DM, Watson DA, Eddy H, Hamill RJ, et al. Spontaneous, nontraumatic gangrene due to Clostridium septicum. Clin Infect Dis. 1990;12:286–296. doi: 10.1093/clinids/12.2.286. [DOI] [PubMed] [Google Scholar]
  • 28.Kuzma J, Zavala-Meneses SG, Skultety L, Chmelar D, Ficík J, et al. Antibiotic resistance and biofilm-forming ability of α-toxin-positive Clostridium septicum isolates worsen patient prognosis. APMIS. 2023;131:434–441. doi: 10.1111/apm.13338. [DOI] [PubMed] [Google Scholar]
  • 29.Macfarlane S, Hopkins MJ, Macfarlane GT. Toxin synthesis and mucin breakdown are related to swarming phenomenon in Clostridium septicum. Infect Immun. 2001;69:1120–1126. doi: 10.1128/IAI.69.2.1120-1126.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kennedy CL, Krejany EO, Young LF, O’Connor JR, Awad MM, et al. The alpha-toxin of Clostridium septicum is essential for virulence. Mol Microbiol. 2005;57:1357–1366. doi: 10.1111/j.1365-2958.2005.04774.x. [DOI] [PubMed] [Google Scholar]
  • 31.Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, et al. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon. 2010;55:61–72. doi: 10.1016/j.toxicon.2009.06.037. [DOI] [PubMed] [Google Scholar]
  • 32.Popoff MR, Bouvet P. Clostridial toxins. Future Microbiol. 2009;4:1021–1064. doi: 10.2217/fmb.09.72. [DOI] [PubMed] [Google Scholar]
  • 33.Melton JA, Parker MW, Rossjohn J, Buckley JT, Tweten RK. The identification and structure of the membrane-spanning domain of the Clostridium septicum alpha toxin. J Biol Chem. 2004;279:14315–14322. doi: 10.1074/jbc.M313758200. [DOI] [PubMed] [Google Scholar]
  • 34.Kennedy CL, Smith DJ, Lyras D, Chakravorty A, Rood JI. Programmed cellular necrosis mediated by the pore-forming alpha-toxin from Clostridium septicum. PLoS Pathog. 2009;5:e1000516. doi: 10.1371/journal.ppat.1000516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Smith-Slatas CL, Bourque M, Salazar JC. Clostridium septicum infections in children: a case report and review of the literature. Pediatrics. 2006;117:e796–805. doi: 10.1542/peds.2005-1074. [DOI] [PubMed] [Google Scholar]
  • 36.Grégoire M, Tadié J-M, Uhel F, Gacouin A, Piau C, et al. Frontline science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock. J Leukoc Biol. 2017;101:1281–1287. doi: 10.1189/jlb.5HI0316-128RR. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Thomas P, Abdel-Glil MY, Subbaiyan A, Busch A, Eichhorn I, et al. First comparative analysis of Clostridium septicum genomes provides insights into the taxonomy, species genetic diversity, and virulence related to gas gangrene. Front Microbiol. 2021;12:771945. doi: 10.3389/fmicb.2021.771945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tran HA, Myint E. Fulminant Clostridium septicum myonecrosis in well controlled diabetes: a case report. J Med Case Rep. 2007;1:119. doi: 10.1186/1752-1947-1-119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Aldape MJ, Bayer CR, Rice SN, Bryant AE, Stevens DL. Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection. Int J Antimicrob Agents. 2018;52:469–473. doi: 10.1016/j.ijantimicag.2018.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gabay EL, Rolfe RD, Finegold SM. Susceptibility of Clostridium septicum to 23 antimicrobial agents. Antimicrob Agents Chemother. 1981;20:852–853. doi: 10.1128/AAC.20.6.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sárvári KP, Schoblocher D. The antibiotic susceptibility pattern of gas gangrene-forming Clostridium spp. clinical isolates from South-Eastern Hungary. Infect Dis. 2020;52:196–201. doi: 10.1080/23744235.2019.1696472. [DOI] [PubMed] [Google Scholar]
  • 42.Leal J, Gregson DB, Ross T, Church DL, Laupland KB. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000–2006. J Infect. 2008;57:198–203. doi: 10.1016/j.jinf.2008.06.018. [DOI] [PubMed] [Google Scholar]
  • 43.Bonne SL, Kadri SS. Evaluation and management of necrotizing soft tissue infections. Infect Dis Clin North Am. 2017;31:497–511. doi: 10.1016/j.idc.2017.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cline KA, Turnbull TL. Clostridial myonecrosis. Ann Emerg Med. 1985;14:459–466. doi: 10.1016/s0196-0644(85)80292-4. [DOI] [PubMed] [Google Scholar]
  • 45.Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51:344–362. doi: 10.1067/j.cpsurg.2014.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, et al. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020;26:8–17. doi: 10.1016/j.cmi.2019.06.031. [DOI] [PubMed] [Google Scholar]
  • 47.Runer A, Schneider F, Mayr R, Dammerer D, Roth T, et al. Blistering of the entire lower limb after knee arthroscopy: benign subcutaneous emphysema, gas gangrene or necrotizing fasciitis? A case report and review of the literature. Trauma Case Rep. 2021;35:100513. doi: 10.1016/j.tcr.2021.100513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Leiblein M, Wagner N, Adam EH, Frank J, Marzi I, et al. Clostridial gas gangrene - a rare but deadly infection: case series and comparison to other necrotizing soft tissue infections. Orthop Surg. 2020;12:1733–1747. doi: 10.1111/os.12804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.van Samkar G, van der Hoeven J, Hollmann MW, Goslings JC. Lethal complication after abdominal wall reduction. J Plastic Reconstr Aesth Surg. 2009;62:e387–e390. doi: 10.1016/j.bjps.2007.12.047. [DOI] [PubMed] [Google Scholar]
  • 50.Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59:147–159. doi: 10.1093/cid/ciu296. [DOI] [PubMed] [Google Scholar]
  • 51.Goldstein EJC, Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–710. doi: 10.1086/511638. [DOI] [PubMed] [Google Scholar]
  • 52.Allaw F, Wehbe S, Kanj SS. Necrotizing fasciitis: an update on epidemiology, diagnostic methods, and treatment. Curr Opin Infect Dis. 2024;37:105–111. doi: 10.1097/QCO.0000000000000988. [DOI] [PubMed] [Google Scholar]
  • 53.Stevens DL, Bryant AE, Hackett SP. Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis. 1995;20:S154–S157. doi: 10.1093/clinids/20.supplement_2.s154. [DOI] [PubMed] [Google Scholar]
  • 54.Abdulkareem A, D’Souza RS, Shogbesan O, Donato A. A case of rituximab-induced necrotizing fasciitis and a review of the literature. Case Rep Hematol. 2017;2017:6971027. doi: 10.1155/2017/6971027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Ben Ismail I, Hammami N, Hakim Z, Rebii S, Zoghlami A. Clostridial abdominal wall gas gangrene secondary to sigmoid cancer perforation. ANZ J Surg. 2021;91:2851–2852. doi: 10.1111/ans.16860. [DOI] [PubMed] [Google Scholar]
  • 56.Bickerton S, Awopetu A, Abood A, Lee H, Lane T, et al. Atraumatic Clostridium septicum myonecrosis presenting as upper limb ischaemia in a patient with undiagnosed bowel cancer. Ann R Coll Surg Engl. 2022;104:e95–e97. doi: 10.1308/rcsann.2021.0153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Chen LL, Tayban K, Caravanos C, Shaz D, Halpern NA. Necrotizing fasciitis associated with malignancy. J Am Assoc Nurse Pract. 2020;32:109–112. doi: 10.1097/JXX.0000000000000251. [DOI] [PubMed] [Google Scholar]
  • 58.Contou D, Lecronier M, Bitot V, Hersant B, Zakine A, et al. Fatal Clostridium septicum multifocal myonecrosis in a previously healthy 25-year-old man: role of NSAIDs? Med Mal Infect. 2017;47:432–434. doi: 10.1016/j.medmal.2017.06.002. [DOI] [PubMed] [Google Scholar]
  • 59.Cullinane C, Earley H, Tormey S. Deadly combination: Clostridium septicum and colorectal malignancy. BMJ Case Rep. 2017;2017:bcr–2017. doi: 10.1136/bcr-2017-222759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Engen RM, Killien EY, Davis JL, Symons JM, Hartmann SM. C septicum complicating hemolytic uremic syndrome: survival without surgical intervention. Pediatrics. 2017;139:e20161362. doi: 10.1542/peds.2016-1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gray KM, Padilla PL, Sparks B, Dziewulski P. Distant myonecrosis by atraumatic Clostridium septicum infection in a patient with metastatic breast cancer. IDCases. 2020;20:e00784. doi: 10.1016/j.idcr.2020.e00784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Hechter S, Patel V, Bommu VJL, Patel P, Ao X, et al. Necrotizing fasciitis: a life-threatening infection due to Clostridium species. Cureus. 2022;14:e22315. doi: 10.7759/cureus.22315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Hussain C, Ball MK, McGwire BS. Multidrug-resistant bovine Salmonellosis predisposing for severe human Clostridial myonecrosis. Am J Case Rep. 2019;20:268–273. doi: 10.12659/AJCR.913472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Mytinger A, Kraai EP. A man with severe back pain. Ann Emerg Med. 2017;69:513–526. doi: 10.1016/j.annemergmed.2016.10.015. [DOI] [PubMed] [Google Scholar]
  • 65.Parmar P, Feder J, Pham-Huy A. Clostridium septicum myonecrosis in a pediatric patient with a self-reported penicillin allergy. J Assoc Med Microbiol Infect Dis Can. 2021;6:325–329. doi: 10.3138/jammi-2020-0039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Saunders RN, Hayakawa E, Gibson CJ, Chapman AJ. Clostridium septicum myonecrosis secondary to an occult small bowel adenocarcinoma. J Gastrointest Canc. 2019;50:1001–1004. doi: 10.1007/s12029-018-0168-2. [DOI] [PubMed] [Google Scholar]
  • 67.Senghaas A, Kremer T, Schmidt VJ, Harhaus L, Hirche C, et al. Sliding free transverse rectus abdominis myocutaneous flap for closure of A massive abdominal wall defect: a case report. Microsurgery. 2019;39:174–177. doi: 10.1002/micr.30309. [DOI] [PubMed] [Google Scholar]
  • 68.Sivasubramanian G. Rapidly progressive and fatal distant spontaneous gas gangrene due to Clostridium septicum after biopsy of malignant cecal mass. IDCases. 2021;24:e01129. doi: 10.1016/j.idcr.2021.e01129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Thompson KM, Kruse BT, Hedges MAS. Atraumatic Clostridial myonecrosis in an immunocompromised host. J Emerg Med. 2018;54:e121–e123. doi: 10.1016/j.jemermed.2018.01.036. [DOI] [PubMed] [Google Scholar]
  • 70.Wongboonsin J, Duran A, Johnson JR. Infectious Pneumorachis due to Clostridium septicum. J Gen Intern Med. 2020;35:2197–2198. doi: 10.1007/s11606-020-05827-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Stoddard N, Grewal M, Lavoie N, Krishna A. Fatal Clostridium septicum myonecrosis from gastric perforation: a case report. Anaerobe. 2021;72:102445. doi: 10.1016/j.anaerobe.2021.102445. [DOI] [PubMed] [Google Scholar]
  • 72.Saiyed A, Datta D. A middle-aged woman with hematochezia, hypotension, and leg cramps. Chest. 2020;158:e21–e24. doi: 10.1016/j.chest.2020.02.034. [DOI] [PubMed] [Google Scholar]
  • 73.Slezak M, Smolar M, Drobna Saniova B, Hosala M, Miklusica J. Clostridium septicum foot gangrene associated with colorectal cancer. Neuro Endocrinol Lett. 2022;43:57–64. [PubMed] [Google Scholar]
  • 74.Rimawi BH, Graybill W, Pierce JY, Kohler M, Eriksson EA, et al. Necrotizing fasciitis and toxic shock syndrome from Clostridium septicum following a term cesarean delivery. Case Rep Obstet Gynecol. 2014;2014:724302. doi: 10.1155/2014/724302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Zurmeyer S, Fotopoulou C, Braicu E, Schlichting U, Sehouli J. Clostridium septicum can cause distant myonecrosis in patients with ovarian cancer. Anticancer Res. 2013;33:1585–1589. [PubMed] [Google Scholar]
  • 76.Barbour SA, King W. The safe and effective use of allograft tissue--an update. Am J Sports Med. 2003;31:791–797. doi: 10.1177/03635465030310052801. [DOI] [PubMed] [Google Scholar]
  • 77.Jing HD, Li L, Tian JY, Jiang DP. Clostridium septicum-induced gangrene in the right lower extremity complicating pneumatosis in the right ventricle and the pulmonary artery and occlusion of right femoral artery: a case report. BMC Infect Dis. 2021;21:957. doi: 10.1186/s12879-021-06653-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Winter E, Dommke A, Bongers-Binder S, Eiring P, Weise K. Exogenously acquired Clostridium septicum gas gangrene--a case report. Swiss Surg. 1998:316–318. [PubMed] [Google Scholar]
  • 79.Chin RL, Martinez R, Garmel G. Gas gangrene from subcutaneous insulin administration. Am J Emerg Med. 1993;11:622–625. doi: 10.1016/0735-6757(93)90018-7. [DOI] [PubMed] [Google Scholar]
  • 80.Kirchweger P, Wundsam H, Bosse F, Fritz A, Kratzer T, et al. Systematic literature review and meta-analysis of Clostridium septicum aortitis. J Vasc Surg. 2022;76:595–604. doi: 10.1016/j.jvs.2022.02.029. [DOI] [PubMed] [Google Scholar]
  • 81.Sanchez-Vicente JL, Contreras-Díaz M, López-Herrero F, Martínez-Borrego A, Galván-Ledesma A, et al. Clostridium septicum endogenous endophthalmitis as the initial manifestation of colorectal carcinoma: clinical case report and literature review. Ocul Immunol Inflamm. 2022;30:348–354. doi: 10.1080/09273948.2020.1799039. [DOI] [PubMed] [Google Scholar]
  • 82.Manwani B, Xu Y, El Sahly HM. Hepatic abscesses due to Clostridium septicum infection and its association with colonic adenocarcinoma: a case report and literature review. Clin J Gastroenterol. 2020;13:66–72. doi: 10.1007/s12328-019-01002-9. [DOI] [PubMed] [Google Scholar]
  • 83.Macha K, Giede-Jeppe A, Lücking H, Coras R, Huttner HB, et al. Ischaemic stroke and Clostridium septicum sepsis and meningitis in a patient with occult colon carcinoma - a case report and review of the literature. BMC Neurol. 2016;16:239. doi: 10.1186/s12883-016-0755-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Extracorporeal Life Support Organization . ELSO: Ann Arbor, MI, USA; 2017. [19-May-2023]. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support.https://www.elso.org/portals/0/elso%20guidelines%20general%20all%20ecls%20version%201_4.pdf accessed. [Google Scholar]

Articles from Access Microbiology are provided here courtesy of Microbiology Society

RESOURCES